Vita 34 AG
XETRA:V3V
Vita 34 AG
XETRA:V3V
Price:
4.72 EUR
Market Closed
Updated:
Jun 1, 2024
Vita 34 AG
Net Income
|
Vita 34 AG
Net Income Peer Comparison
Comparables:
F
FME
FRE
E
1846
SYAB
Competitive Net Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Vita 34 AG
XETRA:V3V
|
Net Income
-€4.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Net Income
€716.9m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-2%
|
|
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Net Income
€64m
|
CAGR 3-Years
-71%
|
CAGR 5-Years
-56%
|
CAGR 10-Years
-28%
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Net Income
HK$190.6m
|
CAGR 3-Years
25%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Synlab AG
XETRA:SYAB
|
Net Income
€59.2m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Net Income?
Net Income
-4.3m
EUR
-4.3m
EUR
Based on the financial report for Dec 31, 2023, Vita 34 AG's Net Income amounts to -4.3m EUR.
What is Vita 34 AG's Net Income growth rate?
Net Income CAGR 1Y
85%
85%
Over the last year, the Net Income growth was 85%.
You don't have any saved screeners yet
